Medigen Biotechnology Corp.

  • About us
    • About us
    • History
    • Corporate milestones
    • Leadership
  • R&D
    • Clinical trials
    • R&D achievements
    • Collaborations
    • Subsidiaries
  • News
    • Press releases
    • Events
  • ESG
  • Investors
    • Corporate governance
    • Financials
    • Shareholder services
    • Material information
    • FAQs
  • Careers
    • Join us
    • Learning and development
    • Compensation and benefit
    • Sustainable talents
  • Contact
  • 繁體中文
  • 簡體中文
  • English

Press Releases

  • 2014/11/19 Entering of Phase II Study for Enterovirus Vaccine MORE
  • 2014/11/10 Grand Opening of TBG Biotechnology Xiamen Inc. and its Factory Plant in China MORE
  • 2014/10/23 The construction of vaccine plant for Medigen Vaccinology Corp. in Hsinchu Biomedical Park is nearly completed MORE
  • 2014/08/21 Latest business update on Medigen Biotech Corp. MORE
  • 2014/08/07 A strategic investor purchased 8% total shares outstanding of Medigen Vaccinology Corp., a Medgien subsidiary MORE
  • 2014/07/29 Additional information regarding to PI-88 interim analysis MORE
  • 2014/07/28 Result of PI-88's interim analysis MORE
  • 5
  • 6
  • 7

About us

  • About us
  • History
  • Corporate milestones
  • Leadership

R&D

  • Clinical trials
  • R&D achievements
  • Collaborations
  • Subsidiaries

News

  • Press releases
  • Events

ESG

Investors

  • Corporate governance
  • Financials
  • Shareholder services
  • Material information
  • FAQs

Careers

  • Join us
  • Learning and development
  • Compensation and benefit
  • Sustainable talents

Contact

  • Privacy Policy
  • Cookie Policy
Copyright © 2025 Medigen Biotechnology Corp. All Rights Reserved.